Try Calculator
← Back to Compound Library MITOCHONDRIAL

MOTS-c

MOTS-c (Mitochondrial ORF of the 12S rRNA-c) is a naturally occurring 16-amino acid peptide encoded directly in your mitochondrial DNA. Unlike most therapeutic peptides which are synthetic versions of hormones or signaling molecules, MOTS-c is a mitochondrial-derived peptide (MDP) that your body produces naturally in response to metabolic stress and physical exercise. Discovered in 2015 by researchers at the USC Leonard Davis School of Gerontology, MOTS-c represents a paradigm shift in understanding how mitochondria communicate with the rest of the cell. Research has shown that MOTS-c improves insulin sensitivity, prevents diet-induced obesity, enhances physical performance, and may slow certain aspects of metabolic aging. Your natural MOTS-c levels decline with age, and this decline correlates with the metabolic dysfunction characteristic of aging: reduced insulin sensitivity, decreased fat oxidation capacity, lower energy production, and diminished physical performance. Supplementing with exogenous MOTS-c may help restore metabolic function that declines over time. MOTS-c is available through research peptide suppliers. While it has not undergone large-scale human clinical trials, a related synthetic analog (CB4211) has demonstrated safety in Phase 1 human studies, and the compound has extensive preclinical research supporting its metabolic effects.

How It Works

MOTS-c works through multiple interconnected pathways centered on cellular energy metabolism and stress response.

AMPK Activation

The primary mechanism involves activation of AMP-activated protein kinase (AMPK), often called the body’s “metabolic master switch.” MOTS-c inhibits the folate cycle, which is connected to purine biosynthesis. This creates a metabolic stress signal that activates AMPK. When AMPK is activated, cells shift toward:

This is similar to what happens during exercise or fasting—your cells become more efficient at producing and using energy.

Nuclear Translocation and Gene Regulation

MOTS-c has the unique ability to move from the cytoplasm into the nucleus under metabolic stress conditions. Once in the nucleus, it directly regulates gene expression, particularly genes involved in:

This means MOTS-c is not just a metabolic signal—it actively changes which genes are turned on or off in response to metabolic challenges.

Skeletal Muscle Targeting

The primary target tissue appears to be skeletal muscle. Research shows MOTS-c:

This muscle-targeting effect aligns with research showing that exercise naturally increases MOTS-c expression in skeletal muscle by approximately 12-fold.

Exercise Mimetic Effects

MOTS-c has been described as an “exercise mimetic” because it produces some of the same metabolic benefits as physical training:

However, MOTS-c does not replace exercise. Rather, it may amplify the metabolic benefits of training or partially compensate for reduced physical activity in those unable to exercise adequately.

Benefits

MOTS-c has been extensively studied in animal models with consistent findings. Human evidence is more limited but promising.

Improved Insulin Sensitivity

This is the most well-documented effect. In animal studies:

The insulin sensitizing effects were significant even when treatment started late in life, suggesting potential therapeutic value for age-related metabolic dysfunction.

Prevention of Diet-Induced Obesity

Mice treated with MOTS-c while consuming a high-fat diet gained significantly less weight than untreated controls. The compound appears to:

These effects were demonstrated across multiple studies using different obesity-inducing protocols.

Enhanced Physical Performance

One of the most compelling findings from a 2021 Nature Communications study showed that MOTS-c treatment improved physical performance in young, middle-aged, and old mice. Key findings:

roughly 70 human years)

These performance improvements occurred alongside metabolic benefits, suggesting MOTS-c affects both energy metabolism and physical capacity.

Potential Anti-Aging Effects

MOTS-c levels decline with age, and this decline correlates with metabolic dysfunction. Research suggests:

Researchers have proposed MOTS-c as a potential longevity intervention, though human lifespan data is obviously not available.

Cardiovascular Benefits

Animal studies demonstrate several cardiovascular effects:

Reduced Inflammation

MOTS-c downregulates pro-inflammatory cytokines including:

Since chronic low-grade inflammation drives both metabolic disease and aging, this anti- inflammatory effect may contribute to MOTS-c’s broader health benefits.

Bone Health

Recent research shows MOTS-c:

This suggests potential applications for bone health and osteoporosis, though clinical research is needed.

Pancreatic Function and Diabetes Prevention

A 2025 study published in Experimental & Molecular Medicine found:

This pancreatic protective effect adds another layer to MOTS-c’s metabolic benefits beyond insulin sensitivity alone.

What the Science Shows

MOTS-c has substantial preclinical research but limited human clinical data. Here are the key studies:

Lee et al. (2015) – Initial Discovery Study

Published in Cell Metabolism. This landmark paper identified MOTS-c as a mitochondrial- encoded peptide and demonstrated its metabolic effects. Key findings:

mice

This study established MOTS-c as a key metabolic regulator and positioned it as a potential therapeutic for insulin resistance and obesity.

Reynolds et al. (2021) – Exercise and Physical Performance Study Published in Nature Communications. This study explored MOTS-c as an exercise-induced peptide that regulates age-dependent physical decline. Key findings:

12-fold increase)

human years) improved physical capacity and healthspan

This study is particularly important because it demonstrated benefits even with very late-life intervention and confirmed MOTS-c as an exercise-responsive molecule.

Kim et al. (2018) – Nuclear Translocation Study

Published in Cell Metabolism. This study revealed MOTS-c’s ability to enter the nucleus and regulate gene expression. Key findings:

This was a breakthrough finding showing that MOTS-c is not just a metabolic signal but an active regulator of gene expression during stress.

Bone Metabolism Research (2023) Published in Frontiers in Physiology. This research examined MOTS-c’s effects on bone cells. Key findings:

This expands the potential therapeutic applications of MOTS-c beyond metabolic disease.

CB4211 Human Safety Study

CB4211 is a synthetic analog of MOTS-c designed for therapeutic use. A Phase 1a/1b double- blind, placebo-controlled trial in healthy adults found it:

While CB4211 is not identical to MOTS-c, this provides some human safety signal for the class of compounds.

Kong et al. (2025) – Diabetes and Pancreatic Function Published in Experimental & Molecular Medicine. Recent research on MOTS-c’s effects on pancreatic cells and diabetes. Key findings:

This is important because pancreatic beta cell dysfunction is central to type 2 diabetes development. Sources:

homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015.

age-dependent physical decline and muscle homeostasis. Nature Communications. 2021.

to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. 2018. https://pubmed.ncbi.nlm.nih.gov/29983246/

stress, metabolism and aging. Journal of Translational Medicine. 2023.

senescence to delay diabetes. Experimental & Molecular Medicine. 2025.

Suggested Research Protocol

MOTS-c dosing is less established than many other peptides because large-scale human clinical trials have not been conducted. The protocols below are extrapolated from animal research and community experience.

Understanding the Different Approaches

You will see MOTS-c protocols ranging from 200 mcg daily to 10 mg every few days. This wide variation exists because:

longevity)

level Animal studies used 5 to 15 mg/kg doses. Simple weight-based conversion would suggest extremely high human doses, but metabolic scaling between species suggests human equivalent doses are roughly 10-fold lower. The commonly used 5 to 10 mg human dose is a conservative starting point.

Suggested Research Dosage

For active exercisers (training enhancement):

For metabolic support (insulin resistance, obesity):

For longevity and general wellness:

Standard Protocols

All protocols use subcutaneous injection. Standard Protocol:

Weekly Protocol:

Daily Low-Dose Protocol:

Important Notes:

doses than used in humans

Draw Volumes by Vial Size

All calculations assume reconstitution volumes that provide practical measurements on a standard insulin syringe.

5 mg Vial with 1 mL Bacteriostatic Water (5 mg/mL concentration) Dose Volume Units on Syringe 1 mg 0.20 mL 20 units 2.5 mg 0.50 mL 50 units 5 mg 1.00 mL 100 units (full syringe)

Vial duration at 5 mg weekly: 1 week 10 mg Vial with 2 mL Bacteriostatic Water (5 mg/mL concentration) Dose Volume Units on Syringe 1 mg 0.20 mL 20 units 2.5 mg 0.50 mL 50 units 5 mg 1.00 mL 100 units

Vial duration at 5 mg weekly: 2 weeks Vial duration at 5 mg every 5 days: approximately 2 weeks 10 mg Vial with 1 mL Bacteriostatic Water (10 mg/mL concentration) Dose Volume Units on Syringe 1 mg 0.10 mL 10 units 2.5 mg 0.25 mL 25 units 5 mg 0.50 mL 50 units 10 mg 1.00 mL 100 units

Vial duration at 5 mg weekly: 2 weeks This is a more concentrated solution that works well if you prefer smaller injection volumes.

Reconstitution Instructions

depending on vial size and desired concentration)

proper storage)

Side Effects and Safety

MOTS-c is naturally produced by your body, which may contribute to its favorable safety profile. The CB4211 analog has shown good safety in Phase 1 human trials. However, MOTS-c itself has not undergone large-scale human safety studies. Common Side Effects (mild):

Less Common:

What We Do Not Know: MOTS-c has not undergone large-scale human safety trials. Long-term effects are unknown. There are theoretical concerns about cancer risk because MOTS-c may affect cell proliferation pathways. Some research suggests it could be therapeutic for cancer, while other studies raise concerns about potentially promoting certain cancer types.

Contraindications and Precautions

Do Not Use If You Have:

Use With Caution If You Have:

Drug Interactions: No formal drug interaction studies exist. MOTS-c affects glucose metabolism, so if you take diabetes medications (metformin, insulin, GLP-1 agonists, etc.), monitor blood sugar closely and adjust medications as needed under medical supervision. Athletes: MOTS-c is on the WADA (World Anti-Doping Agency) prohibited list. If you compete in tested sports, do not use this compound.

Success Tips

Timing Matters

Morning dosing on an empty stomach is most common. This aligns with your body’s natural fasting state and may enhance metabolic effects. Some users dose before fasted cardio to maximize fat oxidation.

Pair It With Exercise

MOTS-c is described as an exercise mimetic, but that does not mean it replaces exercise. The research suggests it amplifies the benefits of training. Think of it as making your workouts more effective, not as a substitute for them.

Stack Strategically

MOTS-c works through mitochondrial and AMPK pathways. It can be combined with compounds that work through different mechanisms:

pathways)

Track Metabolic Markers

If you have access to bloodwork, tracking these markers before and after a cycle can help you assess response:

Be Patient

The effects of MOTS-c are metabolic optimization, not dramatic overnight changes. Give it time to work. The animal studies showing improved physical performance and insulin sensitivity ran for weeks to months.

Maintain the Basics

MOTS-c enhances metabolic function, but it does not override poor diet or lack of exercise. Use it alongside:

MOTS-c amplifies good habits; it doesn’t compensate for bad ones.

Storage and Handling

Before Reconstitution:

After Reconstitution:

Legal Status

United States: Not FDA approved. Available through research peptide suppliers for research purposes only. WADA Status: Prohibited in competitive sports. MOTS-c is on the World Anti-Doping Agency prohibited list. Research Status: Preclinical data is strong. CB4211 (a related analog) has undergone Phase 1 human safety trials. Full human efficacy trials for MOTS-c itself have not been completed.

Frequently Asked Questions

How long until I see results from MOTS-c? MOTS-c works at a fundamental metabolic level, so changes are gradual rather than dramatic. Some users report improved energy and workout performance within 1-2 weeks. More significant changes in body composition, insulin sensitivity, or metabolic markers typically become apparent after 4-8 weeks of consistent use. The animal studies showing robust metabolic improvements ran for 8-16 weeks. How is MOTS-c different from other fat loss peptides? MOTS-c works at the mitochondrial level through AMPK activation. It does not suppress appetite like GLP-1 drugs (semaglutide, tirzepatide), does not target fat cells directly like adipotide, and does not stimulate lipolysis like growth hormone. Instead, it improves how your cells use energy overall—making them better at burning fat, handling glucose, and adapting to metabolic stress. Is MOTS-c the same as exercise? No. MOTS-c is described as an “exercise mimetic” because it triggers some of the same metabolic pathways that exercise does (AMPK activation, improved glucose handling, enhanced fat oxidation). However, exercise provides many benefits beyond what any single compound can replicate: mechanical stress on muscles, cardiovascular conditioning, bone density maintenance, neurological benefits, and countless other adaptations. MOTS-c may amplify the metabolic benefits of training or partially compensate for reduced activity, but it cannot replace exercise. Why do MOTS-c levels decline with age? This is not fully understood. Mitochondrial function declines with age—mitochondria become less efficient, accumulate damage, and produce more reactive oxygen species. MOTS-c production appears to follow this decline. Since MOTS-c is encoded in mitochondrial DNA rather than nuclear DNA, its production is likely tied to overall mitochondrial health. Restoring MOTS-c levels may help counteract some aspects of metabolic aging. Can I combine MOTS-c with GLP-1 drugs like semaglutide or tirzepatide? There is no research on this specific combination. MOTS-c works through different mechanisms than GLP-1 agonists (mitochondrial/AMPK pathways vs. incretin hormone signaling), so theoretically they could be complementary. MOTS-c does not suppress appetite the way GLP-1 drugs do. However, this is speculative—no clinical data exists on combining them, and both affect glucose metabolism, so careful monitoring would be essential. Will MOTS-c help me lose weight? Animal studies show it prevents diet-induced obesity and improves metabolic markers. Whether this translates to meaningful weight loss in humans who are not eating a controlled laboratory diet is unknown. MOTS-c enhances metabolic efficiency—it helps your body burn fat better and handle glucose more effectively—but it does not suppress appetite or create the dramatic caloric deficit that GLP-1 drugs produce. Realistic expectations: improved body composition over time with proper diet and exercise, not rapid weight loss. Is MOTS-c safe long-term? Unknown. Large-scale human safety data does not exist. The fact that MOTS-c is naturally produced by your body is encouraging, and the CB4211 analog showed good safety in Phase 1 trials. However, exogenous supplementation at doses higher than your body naturally produces may have different effects than endogenous production. Until long-term human studies are completed, conservative cycling (rather than continuous use) seems prudent. Can I use MOTS-c if I have diabetes? MOTS-c affects glucose metabolism and insulin sensitivity. If you have type 2 diabetes and are on medication, MOTS-c could potentially improve insulin sensitivity, which might require adjusting your diabetes medications to avoid hypoglycemia. This must be done under medical supervision with careful blood glucose monitoring. If you have type 1 diabetes, there is no safety data—avoid use unless under direct medical supervision. The research is promising for metabolic health, but diabetes requires medical management, not self-experimentation. Does MOTS-c affect hormone levels? MOTS-c is not hormonal and does not directly affect testosterone, estrogen, growth hormone, thyroid hormones, or cortisol. It works through metabolic signaling pathways (AMPK, gene expression) rather than endocrine signaling. However, improved metabolic health can have indirect effects on hormone balance—for example, better insulin sensitivity can improve sex hormone levels in people with metabolic dysfunction.

References

metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454. https://pubmed.ncbi.nlm.nih.gov/25738459/

mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12:470.

translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. 2018;28(3):516-524.

mechanisms related to stress, metabolism and aging. Journal of Translational Medicine. 2023;21:36. https://pubmed.ncbi.nlm.nih.gov/36732765/

pancreatic islet cell senescence to delay diabetes. Experimental & Molecular Medicine. 2025. https://pubmed.ncbi.nlm.nih.gov/39779996/

mitochondrial-derived peptide in human aging and age-related diseases. International Journal of Molecular Sciences. 2022;23(19):11991.

signaling. American Journal of Physiology-Endocrinology and Metabolism. 2021;320(4):E680-E690. https://pubmed.ncbi.nlm.nih.gov/33522388/

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.

Get In Touch